Krytantek: Clinical Trials

2 trials of Krytantek, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Krytantek: new trials by email Literature Review of Krytantek trials Research Report on Krytantek

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)
PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic - Primary Open-angle Glaucoma
Phase 3TerminatedLaboratorios Sophia S.A de C.V.512017-11-062025-03-06
Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Ganforti, Krytantek - Glaucoma Primary Open Angle
CompletedAllergan S.A. DE C.V..902011-02-012012-11-30

Conditions studied

Glaucoma, Open-Angle (2)  ·  Glaucoma (1)  ·  Ocular Hypertension (1)

Sponsors

Allergan S.A. DE C.V.. (1)  ·  Laboratorios Sophia S.A de C.V. (1)

Countries

Mexico (2)  ·  Colombia (1)

Top investigators

Jose A Paczka, MD (1)  ·  Karen Ortiz (1)  ·  Leopoldo Baiza, MD (1)

Results publications

PMID 25527295, PMID 41737851